The Effects of Curcumin and Flavokavain B on the Oncolytic Activity of Vesicular Stomatitis Virus

ASU Author/Contributor (non-ASU co-authors, if there are any, appear on document)
Dylan Fehl (Creator)
Appalachian State University (ASU )
Web Site:
Maryam Ahmed

Abstract: A promising cancer treatment modality is the use of oncolytic viruses to kill cancer cells. One virus that is currently being studied as an oncolytic agent is vesicular stomatitis virus (VSV). We are interested in developing the rM51R-M virus, a matrix (M) protein mutant of VSV, as a candidate oncolytic agent due to its capacity to kill cancer cells and its low virulence in vivo; however, prostate cancer cell lines like PC-3 are resistant to infection. Studies have shown that the transcription factor NF-kB is constitutively active in PC-3 cells, suggesting a role for the induction of the antiviral immune response. We hypothesize that the inhibition of NF-kB in cancer cells will render them susceptible to VSV. Our goal is to determine the ability of natural compounds (flavokavain B and curcumin), which inhibit NF-kB, to promote VSV induced oncolysis. Our results show that curcumin potentiated VSV-induced oncolysis after 24 hours post-infection; however flavokavain B did not. Neither curcumin nor flavokavain B decreased viral protein expression. Additionally, pretreatment of cells with curcumin prior to infection led to a decrease in expression of the antiapoptotic protein, BCL-XL. These results suggest that natural products have the potential to synergize with oncolytic VSV therapies.

Additional Information

Fehl, D. (2013). The Effects of Curcumin and Flavokavain B on the Oncolytic Activity of Vesicular Stomatitis Virus. Unpublished master’s thesis. Appalachian State University, Boone, NC.
Language: English
Date: 2013
Oncolytic Virus, Vesicular Stomatitis Virus, Cell Signaling, Natural Compounds, Cancer Cell Killing

Email this document to